Unlocking Potential: Biodexa Pharmaceutical's (NASDAQ: BDRX) MTX110 Study Progress Triggers Trading Frenzy
Recent announcement on $BDRX brings substantial volatility during today's trading session, experiencing gains of nearly 150% various points.
Source: microcapdaily.com